Loading…

Evonik's proposed acquisition of PeroxyChem for $625 million is being challenged by the Federal Trade Commission, which will file a lawsuit to block the deal. The acquisition was signed in late 2018 and expected to close by mid-2019.
“It is disappointing that the FTC has taken this step to block the acquisition in the highly competitive hydrogen peroxide industry.”adhesivesmag.com
Summarized from public sources; check the original articles before acting on it.